ID   RHAG_HUMAN              Reviewed;         409 AA.
AC   Q02094; B2R8T8; O43514; O43515; Q7L8L3; Q9H454;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   10-MAY-2017, entry version 149.
DE   RecName: Full=Ammonium transporter Rh type A;
DE   AltName: Full=Erythrocyte membrane glycoprotein Rh50;
DE   AltName: Full=Erythrocyte plasma membrane 50 kDa glycoprotein;
DE            Short=Rh50A;
DE   AltName: Full=Rhesus blood group family type A glycoprotein;
DE            Short=Rh family type A glycoprotein;
DE            Short=Rh type A glycoprotein;
DE   AltName: Full=Rhesus blood group-associated ammonia channel;
DE   AltName: Full=Rhesus blood group-associated glycoprotein;
DE   AltName: CD_antigen=CD241;
GN   Name=RHAG; Synonyms=RH50;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ASP-242.
RC   TISSUE=Bone marrow, and Liver;
RX   PubMed=1417776; DOI=10.1042/bj2870223;
RA   Ridgwell K., Spurr N.K., Laguda B., Macgeoch C., Avent N.D.,
RA   Tanner M.J.A.;
RT   "Isolation of cDNA clones for a 50 kDa glycoprotein of the human
RT   erythrocyte membrane associated with Rh (rhesus) blood-group antigen
RT   expression.";
RL   Biochem. J. 287:223-228(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=9442063; DOI=10.1074/jbc.273.4.2207;
RA   Huang C.-H.;
RT   "The human Rh50 glycoprotein gene. Structural organization and
RT   associated splicing defect resulting in Rh(null) disease.";
RL   J. Biol. Chem. 273:2207-2213(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ILE-270.
RC   TISSUE=Heart;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-52, AND TISSUE SPECIFICITY.
RX   PubMed=9473510; DOI=10.1006/bbrc.1997.8023;
RA   Iwamoto S., Omi T., Yamasaki M., Okuda H., Kawano M., Kajii E.;
RT   "Identification of 5' flanking sequence of RH50 gene and the core
RT   region for erythroid-specific expression.";
RL   Biochem. Biophys. Res. Commun. 243:233-240(1998).
RN   [7]
RP   PROTEIN SEQUENCE OF 1-39.
RX   PubMed=3146980; DOI=10.1042/bj2561043;
RA   Avent N.D., Ridgwell K., Mawby W.J., Tanner M.J.A., Anstee D.J.,
RA   Kumpel B.;
RT   "Protein-sequence studies on Rh-related polypeptides suggest the
RT   presence of at least two groups of proteins which associate in the
RT   human red-cell membrane.";
RL   Biochem. J. 256:1043-1046(1988).
RN   [8]
RP   FUNCTION.
RX   PubMed=11062476; DOI=10.1038/81656;
RA   Marini A.-M., Matassi G., Raynal V., Andre B., Cartron J.-P.,
RA   Cherif-Zahar B.;
RT   "The human Rhesus-associated RhAG protein and a kidney homologue
RT   promote ammonium transport in yeast.";
RL   Nat. Genet. 26:341-344(2000).
RN   [9]
RP   FUNCTION.
RX   PubMed=11861637; DOI=10.1074/jbc.C200060200;
RA   Westhoff C.M., Ferreri-Jacobia M., Mak D.-O.D., Foskett J.K.;
RT   "Identification of the erythrocyte Rh blood group glycoprotein as a
RT   mammalian ammonium transporter.";
RL   J. Biol. Chem. 277:12499-12502(2002).
RN   [10]
RP   CHARACTERIZATION.
RX   PubMed=14966114; DOI=10.1074/jbc.M311853200;
RA   Westhoff C.M., Siegel D.L., Burd C.G., Foskett J.K.;
RT   "Mechanism of genetic complementation of ammonium transport in yeast
RT   by human erythrocyte Rh-associated glycoprotein.";
RL   J. Biol. Chem. 279:17443-17448(2004).
RN   [11]
RP   VARIANT RHN ASN-79.
RX   PubMed=8563755; DOI=10.1038/ng0296-168;
RA   Cherif-Zahar B., Raynal V., Gane P., Mattei M.-G., Bailly P.,
RA   Gibbs B., Colin Y., Cartron J.-P.;
RT   "Candidate gene acting as a suppressor of the RH locus in most cases
RT   of Rh-deficiency.";
RL   Nat. Genet. 12:168-173(1996).
RN   [12]
RP   VARIANT RHN GLU-279.
RX   PubMed=9454778;
RA   Hyland C.A., Cherif-Zahar B., Cowley N., Raynal V., Parkes J.,
RA   Saul A., Cartron J.-P.;
RT   "A novel single missense mutation identified along the RH50 gene in a
RT   composite heterozygous Rhnull blood donor of the regulator type.";
RL   Blood 91:1458-1463(1998).
RN   [13]
RP   VARIANT RHN GLU-279.
RX   PubMed=9716608;
RA   Huang C.-H., Liu Z., Cheng G., Chen Y.;
RT   "Rh50 glycoprotein gene and rhnull disease: a silent splice donor is
RT   trans to a Gly279-->Glu missense mutation in the conserved
RT   transmembrane segment.";
RL   Blood 92:1776-1784(1998).
RN   [14]
RP   VARIANTS RHN ARG-280 AND VAL-380, AND VARIANT ILE-270.
RX   PubMed=10467273;
RX   DOI=10.1002/(SICI)1096-8652(199909)62:1<25::AID-AJH5>3.0.CO;2-K;
RA   Huang C.-H., Cheng G., Liu Z., Chen Y., Reid M.E., Halverson G.,
RA   Okubo Y.;
RT   "Molecular basis for Rh(null) syndrome: identification of three new
RT   missense mutations in the Rh50 glycoprotein gene.";
RL   Am. J. Hematol. 62:25-32(1999).
RN   [15]
RP   INVOLVEMENT IN OHST, VARIANTS OHST ARG-61 AND SER-65, CHARACTERIZATION
RP   OF VARIANTS OHST ARG-61 AND SER-65, FUNCTION, TISSUE SPECIFICITY,
RP   SUBCELLULAR LOCATION, AND GLYCOSYLATION.
RX   PubMed=18931342; DOI=10.1182/blood-2008-07-171140;
RA   Bruce L.J., Guizouarn H., Burton N.M., Gabillat N., Poole J.,
RA   Flatt J.F., Brady R.L., Borgese F., Delaunay J., Stewart G.W.;
RT   "The monovalent cation leak in overhydrated stomatocytic red blood
RT   cells results from amino acid substitutions in the Rh-associated
RT   glycoprotein.";
RL   Blood 113:1350-1357(2009).
RN   [16]
RP   VARIANTS GLU-106; GLN-164 AND LEU-227, AND FUNCTION.
RX   PubMed=19744193; DOI=10.1111/j.1423-0410.2009.01243.x;
RA   Tilley L., Green C., Poole J., Gaskell A., Ridgwell K., Burton N.M.,
RA   Uchikawa M., Tsuneyama H., Ogasawara K., Akkoek C.A., Daniels G.;
RT   "A new blood group system, RHAG: three antigens resulting from amino
RT   acid substitutions in the Rh-associated glycoprotein.";
RL   Vox Sang. 98:151-159(2010).
RN   [17]
RP   VARIANT OHST SER-65, CHARACTERIZATION OF VARIANT OHST SER-65, AND
RP   FUNCTION.
RX   PubMed=21849667; DOI=10.1152/ajpcell.00054.2011;
RA   Stewart A.K., Shmukler B.E., Vandorpe D.H., Rivera A., Heneghan J.F.,
RA   Li X., Hsu A., Karpatkin M., O'Neill A.F., Bauer D.E., Heeney M.M.,
RA   John K., Kuypers F.A., Gallagher P.G., Lux S.E., Brugnara C.,
RA   Westhoff C.M., Alper S.L.;
RT   "Loss-of-function and gain-of-function phenotypes of stomatocytosis
RT   mutant RhAG F65S.";
RL   Am. J. Physiol. 301:C1325-C1343(2011).
RN   [18]
RP   CHARACTERIZATION OF VARIANT OHST SER-65, FUNCTION, SUBCELLULAR
RP   LOCATION, GLYCOSYLATION, AND TISSUE SPECIFICITY.
RX   PubMed=22012326; DOI=10.1152/ajpcell.00092.2011;
RA   Genetet S., Ripoche P., Picot J., Bigot S., Delaunay J.,
RA   Armari-Alla C., Colin Y., Mouro-Chanteloup I.;
RT   "Human RhAG ammonia channel is impaired by the Phe65Ser mutation in
RT   overhydrated stomatocytic red cells.";
RL   Am. J. Physiol. 302:C419-C428(2012).
RN   [19]
RP   VARIANT ILE-270.
RX   PubMed=27535533; DOI=10.1038/nature19057;
RG   Exome Aggregation Consortium;
RA   Lek M., Karczewski K.J., Minikel E.V., Samocha K.E., Banks E.,
RA   Fennell T., O'Donnell-Luria A.H., Ware J.S., Hill A.J., Cummings B.B.,
RA   Tukiainen T., Birnbaum D.P., Kosmicki J.A., Duncan L.E., Estrada K.,
RA   Zhao F., Zou J., Pierce-Hoffman E., Berghout J., Cooper D.N.,
RA   Deflaux N., DePristo M., Do R., Flannick J., Fromer M., Gauthier L.,
RA   Goldstein J., Gupta N., Howrigan D., Kiezun A., Kurki M.I.,
RA   Moonshine A.L., Natarajan P., Orozco L., Peloso G.M., Poplin R.,
RA   Rivas M.A., Ruano-Rubio V., Rose S.A., Ruderfer D.M., Shakir K.,
RA   Stenson P.D., Stevens C., Thomas B.P., Tiao G., Tusie-Luna M.T.,
RA   Weisburd B., Won H.H., Yu D., Altshuler D.M., Ardissino D.,
RA   Boehnke M., Danesh J., Donnelly S., Elosua R., Florez J.C.,
RA   Gabriel S.B., Getz G., Glatt S.J., Hultman C.M., Kathiresan S.,
RA   Laakso M., McCarroll S., McCarthy M.I., McGovern D., McPherson R.,
RA   Neale B.M., Palotie A., Purcell S.M., Saleheen D., Scharf J.M.,
RA   Sklar P., Sullivan P.F., Tuomilehto J., Tsuang M.T., Watkins H.C.,
RA   Wilson J.G., Daly M.J., MacArthur D.G.;
RT   "Analysis of protein-coding genetic variation in 60,706 humans.";
RL   Nature 536:285-291(2016).
CC   -!- FUNCTION: Associated with rhesus blood group antigen expression
CC       (PubMed:19744193). May be part of an oligomeric complex which is
CC       likely to have a transport or channel function in the erythrocyte
CC       membrane (PubMed:11062476, PubMed:11861637). Involved in ammonia
CC       transport across the erythrocyte membrane (PubMed:21849667,
CC       PubMed:22012326). Seems to act in monovalent cation transport
CC       (PubMed:18931342, PubMed:21849667). {ECO:0000269|PubMed:11062476,
CC       ECO:0000269|PubMed:11861637, ECO:0000269|PubMed:18931342,
CC       ECO:0000269|PubMed:19744193, ECO:0000269|PubMed:21849667,
CC       ECO:0000269|PubMed:22012326}.
CC   -!- SUBUNIT: Heterotetramer.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000269|PubMed:18931342,
CC       ECO:0000269|PubMed:22012326}; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q02094-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q02094-2; Sequence=VSP_047629, VSP_047630;
CC   -!- TISSUE SPECIFICITY: Erythrocytes. {ECO:0000269|PubMed:18931342,
CC       ECO:0000269|PubMed:22012326, ECO:0000269|PubMed:9473510}.
CC   -!- PTM: Glycoylated. {ECO:0000269|PubMed:18931342,
CC       ECO:0000269|PubMed:22012326}.
CC   -!- DISEASE: Regulator type Rh-null hemolytic anemia (RHN)
CC       [MIM:268150]: Form of chronic hemolytic anemia in which the red
CC       blood cells have a stomatocytosis and spherocytosis morphology, an
CC       increased osmotic fragility, an altered ion transport system, and
CC       abnormal membrane phospholipid organization.
CC       {ECO:0000269|PubMed:10467273, ECO:0000269|PubMed:8563755,
CC       ECO:0000269|PubMed:9454778, ECO:0000269|PubMed:9716608}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- DISEASE: Overhydrated hereditary stomatocytosis (OHST)
CC       [MIM:185000]: An autosomal dominant disorder of red cell membrane
CC       permeability to monovalent cations, characterized by macrocytic
CC       hemolytic anemia of fluctuating severity, circulating erythrocytes
CC       with slit-like lucencies (stomata) evident on fixed, stained
CC       peripheral blood smears. OHST red cells exhibit cation leak,
CC       resulting in elevated cell sodium content with reduced potassium
CC       content. The disease is marked by splenomegaly or
CC       hepatosplenomegaly, cholelithiasis and a strong tendency for iron
CC       overload. {ECO:0000269|PubMed:18931342,
CC       ECO:0000269|PubMed:21849667, ECO:0000269|PubMed:22012326}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the ammonium transporter (TC 2.A.49)
CC       family. Rh subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X64594; CAA45883.1; -; mRNA.
DR   EMBL; AF031548; AAC04247.1; -; mRNA.
DR   EMBL; AF031549; AAC04248.1; -; mRNA.
DR   EMBL; AF237387; AAF78209.1; -; Genomic_DNA.
DR   EMBL; AF237382; AAF78209.1; JOINED; Genomic_DNA.
DR   EMBL; AF237383; AAF78209.1; JOINED; Genomic_DNA.
DR   EMBL; AF237384; AAF78209.1; JOINED; Genomic_DNA.
DR   EMBL; AF237385; AAF78209.1; JOINED; Genomic_DNA.
DR   EMBL; AF237386; AAF78209.1; JOINED; Genomic_DNA.
DR   EMBL; AK313505; BAG36285.1; -; mRNA.
DR   EMBL; AL121950; CAC10519.2; -; Genomic_DNA.
DR   EMBL; AL590244; CAC10519.2; JOINED; Genomic_DNA.
DR   EMBL; AL590244; CAI13085.1; -; Genomic_DNA.
DR   EMBL; AL121950; CAI13085.1; JOINED; Genomic_DNA.
DR   EMBL; CH471081; EAX04337.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX04338.1; -; Genomic_DNA.
DR   CCDS; CCDS4927.1; -. [Q02094-1]
DR   PIR; S29124; S29124.
DR   RefSeq; NP_000315.2; NM_000324.2. [Q02094-1]
DR   UniGene; Hs.120950; -.
DR   ProteinModelPortal; Q02094; -.
DR   BioGrid; 111937; 1.
DR   STRING; 9606.ENSP00000360217; -.
DR   TCDB; 1.A.11.4.3; the ammonium transporter channel (amt) family.
DR   iPTMnet; Q02094; -.
DR   PhosphoSitePlus; Q02094; -.
DR   BioMuta; RHAG; -.
DR   DMDM; 218511807; -.
DR   PaxDb; Q02094; -.
DR   PeptideAtlas; Q02094; -.
DR   PRIDE; Q02094; -.
DR   DNASU; 6005; -.
DR   Ensembl; ENST00000371175; ENSP00000360217; ENSG00000112077. [Q02094-1]
DR   GeneID; 6005; -.
DR   KEGG; hsa:6005; -.
DR   UCSC; uc003ozk.5; human. [Q02094-1]
DR   CTD; 6005; -.
DR   DisGeNET; 6005; -.
DR   GeneCards; RHAG; -.
DR   H-InvDB; HIX0005947; -.
DR   HGNC; HGNC:10006; RHAG.
DR   HPA; HPA055331; -.
DR   MalaCards; RHAG; -.
DR   MIM; 180297; gene.
DR   MIM; 185000; phenotype.
DR   MIM; 268150; phenotype.
DR   neXtProt; NX_Q02094; -.
DR   OpenTargets; ENSG00000112077; -.
DR   Orphanet; 3203; Overhydrated hereditary stomatocytosis.
DR   Orphanet; 71275; Rh deficiency syndrome.
DR   PharmGKB; PA34381; -.
DR   eggNOG; KOG3796; Eukaryota.
DR   eggNOG; ENOG410XTF8; LUCA.
DR   GeneTree; ENSGT00390000005787; -.
DR   HOGENOM; HOG000007656; -.
DR   HOVERGEN; HBG004374; -.
DR   InParanoid; Q02094; -.
DR   KO; K06580; -.
DR   OMA; VTAYACS; -.
DR   PhylomeDB; Q02094; -.
DR   TreeFam; TF314450; -.
DR   Reactome; R-HSA-1237044; Erythrocytes take up carbon dioxide and release oxygen.
DR   Reactome; R-HSA-1247673; Erythrocytes take up oxygen and release carbon dioxide.
DR   Reactome; R-HSA-444411; Rhesus glycoproteins mediate ammonium transport.
DR   ChiTaRS; RHAG; human.
DR   GeneWiki; RHAG; -.
DR   GenomeRNAi; 6005; -.
DR   PRO; PR:Q02094; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112077; -.
DR   CleanEx; HS_RHAG; -.
DR   ExpressionAtlas; Q02094; baseline and differential.
DR   Genevisible; Q02094; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008519; F:ammonium transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0030506; F:ankyrin binding; IPI:UniProtKB.
DR   GO; GO:0035379; F:carbon dioxide transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0022840; F:leak channel activity; IDA:UniProtKB.
DR   GO; GO:0072488; P:ammonium transmembrane transport; IMP:UniProtKB.
DR   GO; GO:0015696; P:ammonium transport; IDA:UniProtKB.
DR   GO; GO:0015701; P:bicarbonate transport; TAS:Reactome.
DR   GO; GO:0015670; P:carbon dioxide transport; IDA:UniProtKB.
DR   GO; GO:0006873; P:cellular ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0048821; P:erythrocyte development; IEA:Ensembl.
DR   GO; GO:0015672; P:monovalent inorganic cation transport; IDA:UniProtKB.
DR   GO; GO:0060586; P:multicellular organismal iron ion homeostasis; IEA:Ensembl.
DR   GO; GO:0015695; P:organic cation transport; IBA:GO_Central.
DR   InterPro; IPR024041; NH4_transpt_AmtB-like_dom.
DR   InterPro; IPR002229; RhesusRHD.
DR   Pfam; PF00909; Ammonium_transp; 1.
DR   PRINTS; PR00342; RHESUSRHD.
DR   SUPFAM; SSF111352; SSF111352; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Ammonia transport; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Glycoprotein;
KW   Hereditary hemolytic anemia; Membrane; Reference proteome;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    409       Ammonium transporter Rh type A.
FT                                /FTId=PRO_0000168199.
FT   TOPO_DOM      1      2       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      3     23       Helical. {ECO:0000255}.
FT   TOPO_DOM     24     51       Extracellular. {ECO:0000255}.
FT   TRANSMEM     52     72       Helical. {ECO:0000255}.
FT   TOPO_DOM     73     79       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     80    100       Helical. {ECO:0000255}.
FT   TOPO_DOM    101    113       Extracellular. {ECO:0000255}.
FT   TRANSMEM    114    134       Helical. {ECO:0000255}.
FT   TOPO_DOM    135    142       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    143    163       Helical. {ECO:0000255}.
FT   TOPO_DOM    164    167       Extracellular. {ECO:0000255}.
FT   TRANSMEM    168    188       Helical. {ECO:0000255}.
FT   TOPO_DOM    189    208       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    209    229       Helical. {ECO:0000255}.
FT   TOPO_DOM    230    239       Extracellular. {ECO:0000255}.
FT   TRANSMEM    240    260       Helical. {ECO:0000255}.
FT   TOPO_DOM    261    268       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    269    291       Helical. {ECO:0000255}.
FT   TOPO_DOM    292    295       Extracellular. {ECO:0000255}.
FT   TRANSMEM    296    318       Helical. {ECO:0000255}.
FT   TOPO_DOM    319    332       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    333    353       Helical. {ECO:0000255}.
FT   TOPO_DOM    354    362       Extracellular. {ECO:0000255}.
FT   TRANSMEM    363    383       Helical. {ECO:0000255}.
FT   TOPO_DOM    384    409       Cytoplasmic. {ECO:0000255}.
FT   CARBOHYD     37     37       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    355    355       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     316    351       PLFTTKLRIHDTCGVHNLHGLPGVVGGLAGIVAVAM -> V
FT                                YGHAGSCTGFLYRNSSCWRSDDRFNSKVASLGTAI (in
FT                                isoform 2). {ECO:0000303|PubMed:9442063}.
FT                                /FTId=VSP_047629.
FT   VAR_SEQ     352    409       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:9442063}.
FT                                /FTId=VSP_047630.
FT   VARIANT      61     61       I -> R (in OHST; strongly enhances
FT                                monovalent cation leak;
FT                                dbSNP:rs863225469).
FT                                {ECO:0000269|PubMed:18931342}.
FT                                /FTId=VAR_076283.
FT   VARIANT      65     65       F -> S (in OHST; enhances monovalent
FT                                cation leak; decreases ammonium fluxes;
FT                                highly decreases STOM expression;
FT                                decreases membrane expression; no effect
FT                                on water permeability;
FT                                dbSNP:rs863225468).
FT                                {ECO:0000269|PubMed:18931342,
FT                                ECO:0000269|PubMed:21849667,
FT                                ECO:0000269|PubMed:22012326}.
FT                                /FTId=VAR_076284.
FT   VARIANT      79     79       S -> N (in RHN; dbSNP:rs121918586).
FT                                {ECO:0000269|PubMed:8563755}.
FT                                /FTId=VAR_006921.
FT   VARIANT     106    106       Q -> E (polymorphism; in Duclos or RHAG1
FT                                antigen (030001)).
FT                                {ECO:0000269|PubMed:19744193}.
FT                                /FTId=VAR_076285.
FT   VARIANT     164    164       K -> Q (polymorphism; in DSLK or RHAG3
FT                                antigen (030003); dbSNP:rs144305805).
FT                                {ECO:0000269|PubMed:19744193}.
FT                                /FTId=VAR_076286.
FT   VARIANT     227    227       S -> L (polymorphism; in Ol(a) or RHAG2
FT                                antigen (030002)).
FT                                {ECO:0000269|PubMed:19744193}.
FT                                /FTId=VAR_076287.
FT   VARIANT     242    242       N -> D (in dbSNP:rs1058063).
FT                                {ECO:0000269|PubMed:1417776}.
FT                                /FTId=VAR_047999.
FT   VARIANT     270    270       V -> I (in dbSNP:rs16879498).
FT                                {ECO:0000269|PubMed:10467273,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:27535533}.
FT                                /FTId=VAR_015855.
FT   VARIANT     279    279       G -> E (in RHN; dbSNP:rs28933991).
FT                                {ECO:0000269|PubMed:9454778,
FT                                ECO:0000269|PubMed:9716608}.
FT                                /FTId=VAR_015856.
FT   VARIANT     280    280       G -> R (in RHN; dbSNP:rs104893987).
FT                                {ECO:0000269|PubMed:10467273}.
FT                                /FTId=VAR_015857.
FT   VARIANT     380    380       G -> V (in RHN; dbSNP:rs121918589).
FT                                {ECO:0000269|PubMed:10467273}.
FT                                /FTId=VAR_015858.
FT   CONFLICT      2      2       R -> C (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT     37     37       N -> P (in Ref. 7; AA sequence).
FT                                {ECO:0000305}.
SQ   SEQUENCE   409 AA;  44198 MW;  F6F024399CC0C88D CRC64;
     MRFTFPLMAI VLEIAMIVLF GLFVEYETDQ TVLEQLNITK PTDMGIFFEL YPLFQDVHVM
     IFVGFGFLMT FLKKYGFSSV GINLLVAALG LQWGTIVQGI LQSQGQKFNI GIKNMINADF
     SAATVLISFG AVLGKTSPTQ MLIMTILEIV FFAHNEYLVS EIFKASDIGA SMTIHAFGAY
     FGLAVAGILY RSGLRKGHEN EESAYYSDLF AMIGTLFLWM FWPSFNSAIA EPGDKQCRAI
     VNTYFSLAAC VLTAFAFSSL VEHRGKLNMV HIQNATLAGG VAVGTCADMA IHPFGSMIIG
     SIAGMVSVLG YKFLTPLFTT KLRIHDTCGV HNLHGLPGVV GGLAGIVAVA MGASNTSMAM
     QAAALGSSIG TAVVGGLMTG LILKLPLWGQ PSDQNCYDDS VYWKVPKTR
//
